Organisation paid for research Program year 2025 Source: CMS Open Payments

Nevada Advanced Pain Specialists

Neither a doctor nor a teaching hospital

Research payments

$526,815

166 payments

Through program year 2025, Nevada Advanced Pain Specialists is reported as receiving $526,815 in research payments, across 166 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$78,576	23
2024	Research	$19,337	18
2023	Research	$33,506	18
2022	Research	$180,136	30
2021	Research	$88,968	38
2020	Research	$83,965	24
2019	Research	$42,328	15

Breakdown

Who paid Research payments · program years 2019–2025

Abbott Laboratories $333,552 92 payments
H. Lundbeck A S $70,331 14 payments
Nevro Corp. $58,612 13 payments
Saluda Medical Americas, Inc. $41,579 29 payments
SI-BONE, Inc. $19,567 15 payments
Vertiflex, Inc. $2,800 2 payments
Foundation Fusion Solutions, LLC $375 1 payment

Studies the money was for Research payments · program years 2019–2025

Dorsal Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) $116,400 7 payments
Interventional, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding Trial of Lu AG09222 for the Prevention of Migraine in Participants With Unsuccessful Prior Preventive Treatments $70,331 14 payments
Chronic Peripheral Polyneuropathy Randomized Trial $57,012 10 payments
Real-World Outcomes Study on Subjects Treated with Radiofrequency Ablation $46,536 7 payments
Distinct $42,254 10 payments
ECAP Study $41,579 29 payments
TARGET: A Post-Approval Study to Evaluate Targeted SCS (DRG) Stimulation for the management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs due to CRPS types I and II $21,086 4 payments
Staci $19,567 15 payments
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator (REALITY) $18,155 12 payments
Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) $10,895 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.